Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
04/27/2015 04/28/2015 04/29/2015 04/30/2015 05/04/2015 Date
68.982(c) 68.797(c) 64(c) 64.31(c) 63.34(c) Last
0 0 125 255 1 469 Volume
+0.09% -0.27% -6.97% +0.48% -1.51% Change
More quotes
Financials (€)
Sales 2015 3 630 M
EBIT 2015 531 M
Net income 2015 294 M
Debt 2015 1 461 M
Yield 2015 1,84%
Sales 2016 3 925 M
EBIT 2016 687 M
Net income 2016 408 M
Debt 2016 1 287 M
Yield 2016 1,99%
PER 2015 39,13
PER 2016 28,62
EV / Sales 2015 3,80x
EV / Sales 2016 3,47x
Capitalization 12 341 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
05/06 | 08:00amPresentation
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB SA
05/04 UCB : ex-dividend day for annual dividend
04/02 DR REDDY LABORATORIES : Labs to Acquire Brands Portfolio of UCB for USD128 Milli..
03/30 Ireland's Horizon to buy U.S. drugmaker Hyperion for $1.1 billion
03/27 UCB : Convening notice to attend the general meeting of shareholders
03/25 UCB : Findings from UCB Pharma SA Yields New Findings on Toxicology (Identificat..
02/12 UCB : Patent Issued for Systems for Administering Medication
02/12 UCB : Patent Issued for Syringe Safety Assembly
01/28 UCB : announces US and EU regulatory filings for the investigational antiepilept..
More news
Sector news : Biopharmaceuticals
06:06a GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Sets Up Medical Health Hospital
06:05a INVESCO VALUE MUNICIPAL SECURITIES : 2014 Vigra Sales Volume in China Leapt 47%
05:47aDJGSK, Fondazione, Ospedale Make EU Submission for Gene Therapy to Treat ADA-SC..
More sector news : Biopharmaceuticals
Comments 
Advertisement
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF